Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter June 1, 2005

Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes

  • Martina Brueckmann , Thomas Bertsch , Siegfried Lang , Tim Sueselbeck , Christian Wolpert , Jens J. Kaden , Carlos Jaramillo , Guenter Huhle , Martin Borggrefe and Karl K. Haase

Abstract

Inflammation within coronary plaques may cause an acute coronary syndrome by promoting rupture and erosion. It was the aim of this study to examine whether markers of inflammation derive from a cardiac or extracardiac source and how their levels develop over time.

Blood samples were taken from patients with acute coronary syndromes (ACS) with proven atherosclerotic lesion(s) of the left coronary artery (n = 13) and from control patients without coronary artery disease (n = 13). Blood was taken from the femoral vein and the coronary sinus vein before and after coronary angioplasty (day 0) and on days 1 and 120.

Levels of tumor necrosis factor-α (TNF-α), interleukin- 6 (IL-6), interleukin-1-receptor antagonist (IL-1 ra) and soluble CD40 ligand (sCD40L) were higher in ACS patients as compared to controls and remained elevated up to day 120. In the long-term time course these markers of inflammation and plaque remodeling slightly decreased in ACS patients. There were no statistically significant differences detectable in the levels of TNF-α, IL-6, IL-1 β, IL-10, IL-1 ra, sCD40L and monocyte chemoattractant protein-1 (MCP-1) in the blood of ACS patients taken from a cardiac source as compared to an extracardiac source (coronary sinus vs. femoral vein).

This study demonstrates the importance of a systemic inflammatory condition in patients with ACS, in whom markers of inflammation are increased as compared to controls. During long-term follow-up the pro-inflammatory activity remains elevated in ACS patients, supporting the concept of a systemic rather than a local vascular inflammation contributing to the development of atherosclerosis.


Corresponding author. Martina Brueckmann, MD, First Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Phone/Fax: +49-621-383-2875, E-mail:

References

1 Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91:2844–50.10.1161/01.CIR.91.11.2844Search in Google Scholar

2 Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kDa gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995; 91:2125–31.10.1161/01.CIR.91.8.2125Search in Google Scholar

3 Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94:2493–503.10.1172/JCI117619Search in Google Scholar

4 Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O’Neill WW. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 2000; 343:915–22.10.1056/NEJM200009283431303Search in Google Scholar

5 Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997; 17:1121–7.10.1161/01.ATV.17.6.1121Search in Google Scholar

6 Haverkate F, Thompson SG, Pyke SD, Gallimore JR, Pepys MB. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 1997; 349:462–6.10.1016/S0140-6736(96)07591-5Search in Google Scholar

7 Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, et al. The prognostic value of C-reactive protein and serum amyloid, a protein in severe unstable angina. N Engl J Med 1994; 331:417–24.10.1056/NEJM199408183310701Search in Google Scholar

8 Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767–72.10.1161/01.CIR.101.15.1767Search in Google Scholar

9 Garcia-Moll X, Coccolo F, Cole D, Kaski JC. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Coll Cardiol 2000; 35:956–62.10.1016/S0735-1097(99)00640-3Search in Google Scholar

10 Zairis MN, Papadaki OA, Manousakis SJ, Thoma MA, Beldekos DJ, Olympios CD, et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 2002; 164:355–9.10.1016/S0021-9150(02)00129-6Search in Google Scholar

11 Enbergs A, Bürger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S. Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 2000; 21:45–52.10.1053/euhj.1999.1763Search in Google Scholar

12 Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001; 358:1533–8.10.1016/S0140-6736(01)06585-0Search in Google Scholar

13 Buffon A, Biasucci LM, Liuzzo G, D’Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5–12.10.1056/NEJMoa012295Search in Google Scholar

14 Spagnoli LG, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G, et al. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol 2002; 40:1579–88.10.1016/S0735-1097(02)02376-8Search in Google Scholar

15 Schönbeck U, Libby P. CD40 signaling and plaque instability. Circ Res 2001; 89:1092–103.10.1161/hh2401.101272Search in Google Scholar

16 Graf D, Korthauer U, Mages HW, Senger G, Kroczek RA. Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 1992; 22:3191–4.10.1002/eji.1830221226Search in Google Scholar

17 Biasucci LM, Liuzzo G, Fantuzzi G, Caligiuri G, Rebuzzi AG, Ginnetti F, et al. Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation 1999; 99:2079–84.10.1161/01.CIR.99.16.2079Search in Google Scholar

18 Biasucci LM, Luizzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, et al. Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 1999; 99:855–60.10.1161/01.CIR.99.7.855Search in Google Scholar

19 Berk BC, Weintraub WS, Alexander RW. Elevation of Creactive protein in active coronary artery disease. Am J Cardiol 1990; 65:168–72.10.1016/0002-9149(90)90079-GSearch in Google Scholar

20 De Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 1982; 47:239–43.10.1136/hrt.47.3.239Search in Google Scholar PubMed PubMed Central

21 Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347:1557–65.10.1056/NEJMoa021993Search in Google Scholar

22 Burke AP, Tracy RP, Kolodgie F, Malcolm GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 2002; 105:2019–23.10.1161/01.CIR.0000015507.29953.38Search in Google Scholar

23 Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy. J Am Med Assoc 2001; 286:2107–13.10.1001/jama.286.17.2107Search in Google Scholar

24 Fiotti N, Giansante C, Ponte E, Delbello C, Calabrese S, Zacchi T, et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis 1999; 145:51–60.10.1016/S0021-9150(99)00013-1Search in Google Scholar

25 Biasucci LM, Liuzzo G, Angiolillo DJ, Sperti G, Maseri A. Inflammation and acute coronary syndromes. Herz 2000; 2:108–12.10.1007/PL00001947Search in Google Scholar

26 Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998; 16:111–35.10.1146/annurev.immunol.16.1.111Search in Google Scholar

27 Sukhova GK, Schönbeck U, Rabkin E, Schoen FJ, Poole AR, Billinghurst RC, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99:2503–9.10.1161/01.CIR.99.19.2503Search in Google Scholar

28 Peng DQ, Zhao SP, Li YF, Li Y, Zhou HN. Elevated soluble CD40 ligand is related to the endothelial adhesion molecules in patients with acute coronary syndromes. Clin Chim Acta 2002; 319:19–26.10.1016/S0009-8981(02)00014-1Search in Google Scholar

29 Heeschen C, Dimmeler S, Hamm C, van den Brand MJ, Boersma E, Zeiher AM, et al. for the Capture Study Investigators. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003; 348:1104–11.10.1056/NEJMoa022600Search in Google Scholar PubMed

30 Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, et al. Soluble CD40L – risk prediction after acute coronary syndromes. Circulation 2003; 108:1049–52.10.1161/01.CIR.0000088521.04017.13Search in Google Scholar PubMed

Received: 2004-5-28
Accepted: 2004-8-23
Published Online: 2005-6-1
Published in Print: 2004-10-1

© Walter de Gruyter

Downloaded on 28.3.2024 from https://www.degruyter.com/document/doi/10.1515/CCLM.2004.232/html
Scroll to top button